iifl-logo

Shilpa Medicare Ltd Historical Data

377.45
(-1.95%)
Oct 6, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Shilpa Medicare Ltd Historical Data

06/09/2025calendar-icon
06/10/2025calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

09-Sep-2025

430

430406.25414.684,1486,68,47,738.5556,273

11-Sep-2025

420.5

427.48416.55418.334,1654,24,15,91228,297

12-Sep-2025

419.48

420.58412.38413.84,0727,50,66,522.9575,761

15-Sep-2025

415

416.55404412.388,77710,46,25,252.984,106

16-Sep-2025

412.53

418.9406.35413.155,8144,40,88,892.830,913

17-Sep-2025

416

416403.28410.655,1475,18,72,189.936,713

18-Sep-2025

410

414.25406.58408.83,3572,81,31,247.222,896

19-Sep-2025

410

418.5406.23412.54,46011,45,99,588.8590,360

22-Sep-2025

412.5

414.75400409.238,46110,93,86,357.251,01,396

23-Sep-2025

412.5

429.68408412.4311,54329,66,78,295.41,28,519

24-Sep-2025

414.8

416.2403.28406.157,9707,48,61,344.161,088

25-Sep-2025

407.5

410.03388396.3512,73218,95,82,881.91,32,467

26-Sep-2025

395.48

395.48383.28385.936,9459,20,69,307.876,279

29-Sep-2025

383

391.95378.28383.656,2185,81,93,448.443,279

30-Sep-2025

385.55

390.5374376.69,51313,28,85,128.151,19,266

01-Oct-2025

380

392378.05389.388,3508,58,69,889.774,211

03-Oct-2025

400

407.7379.8384.9510,7739,09,59,878.81,04,411

06-Oct-2025

384.95

388375.35377.455,0984,52,30,122.9570,456

Shilpa Medicare: Related NEWS

Shilpa Medicare’s Bengaluru units gets USFDA clearance

USFDA conducted the Good Manufacturing Practices (GMP) inspection from October 24 to October 30 in 2024.

16 Jul 2025|02:18 PM
Read More
Shilpa Medicare Receives EU GMP Approval for Bengaluru Manufacturing Unit

The certification came after a successful inspection by the Finnish Medicines Agency on behalf of EMA from March 10 to March 14, 2025

8 May 2025|12:30 AM
Read More
Shilpa Medicare Strikes Global Immuno-Oncology Deal with mAbTree

The partnership will work on a new biological entity (NBE) in the immuno-oncology field to better treat cancer.

18 Mar 2025|01:22 PM
Read More
Top Stocks for Today - 18th March 2025

Here are some of the stocks that may see significant price movement today: Aditya Birla Real Estate, Shilpa Medicare, Swiggy, etc.

18 Mar 2025|06:44 AM
Read More
Shilpa Pharma Lifesciences Clears USFDA Inspection at Raichur Unit-2

No regulatory issues were raised by the USFDA at Unit-2 during the inspection, the company said in a regulatory filing.

16 Mar 2025|11:29 PM
Read More
Shilpa Medicare Gets CDSCO Nod for NAFLD Drug

Shilpa Medicare said it has completed Phase 3 trials for SMLNUD07 – Nor Ursodeoxycholic Acid (Nor UDCA) tablets in 165 NAFLD patients in India.

13 Feb 2025|11:09 PM
Read More
Shilpa Medicare Secures EU GMP Certification for Hyderabad Facility

The certification followed a successful inspection by the European Medicines Agency, Austria, held from September 24 to September 26 at the Nacharam, Hyderabad facility.

23 Dec 2024|01:30 PM
Read More
Shilpa Medicare’s JV Oncosol Gets FDA Nod for IMKELDI

This FDA approval is a milestone in cancer therapy as it presents a more convenient and precise alternative to the traditional tablet forms.

28 Nov 2024|12:41 AM
Read More
Shilpa Medicare Secures Phase III Trial Nod for Recombinant Albumin

  Shilpa Medicare is the first Indian company to gain approval for Phase III trials of Recombinant Human Albumin.

26 Nov 2024|07:49 PM
Read More
Shilpa Medicare Subsidiary Bags European Certification for Nifedipine

The European Directorate for the Quality of Medicines & Healthcare (EDQM) gave Shilpa Pharma Lifesciences, the company's subsidiary, the Certificate of Suitability (CEP) for Nifedipine.

19 Nov 2024|05:28 PM
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.